首页> 外文期刊>Expert opinion on drug delivery >A nanovesicle topical formulation of Bhut Jolokia (hottest capsicum): A potential anti-arthritic medicine
【24h】

A nanovesicle topical formulation of Bhut Jolokia (hottest capsicum): A potential anti-arthritic medicine

机译:Bhut Jolokia(最辣的辣椒)的纳米囊外用制剂:一种潜在的抗关节炎药

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives: Bhut Jolokia is a capsicum variety indigenous to Northeast India and is recognized as the hottest capsicum variety of the world. The ethnobotanical survey revealed that it has potential anti-arthritic activity but its topical adverse events restrict its usability. In the present study, the semipurified capsaicinoids extract of Bhut Jolokia was formulated as a topical formulation via ethosomal nanovesicle approach, which enhanced the acceptability. Methods: Prepared formulation was optimized by surface response methodology and characterized for morphology, zeta potential, differential scanning calorimetry study and permeation and penetration studies. The experimental formulations were characterized on Freunds complete adjuvant-induced chronic arthritis model. Results: Ethosomal nanovesicles prepared with the semipurified capsaicinoids extract demonstrated good anti-arthritic activity in rat model, superior to Thermagel (a marketed formulation of capsaicin) in the reduction of joint swelling and pain throughout the observation period. Nanovesicle formulation showed better tolerability and acceptance on both animal and human models. Results obtained from the study strengthen the potential application of Bhut Jolokia semipurified extract in an ethosomal nanovesicle carrier as a topical analgesic as well as an anti-arthritic. Conclusion: The significant positive results, with reduced irritant effect of the semipurified capsaicinoids extract of Bhut Jolokia-loaded ethosomal nanovesicle carrier, suggest that it could be one of the choices for formulation development in anti-arthritic medicine.
机译:目标:Bhut Jolokia是印度东北部土著的辣椒品种,被公认为世界上最热的辣椒品种。种族植物学调查显示,它具有潜在的抗关节炎活性,但其局部不良事件限制了其可用性。在本研究中,Bhut Jolokia的半纯化辣椒素类提取物通过溶酶体纳米囊泡方法被制成局部制剂,从而提高了可接受性。方法:通过表面响应方法对制备的制剂进行优化,并对其形态,ζ电势,差示扫描量热法研究以及渗透和渗透研究进行表征。在弗氏完全佐剂诱导的慢性关节炎模型上表征了实验制剂。结果:用半纯化的辣椒素样物质提取物制备的核糖体纳米囊在大鼠模型中显示出良好的抗关节炎活性,在整个观察期内,在减少关节肿胀和疼痛方面优于Thermagel(辣椒素的市售制剂)。纳米囊泡制剂在动物和人类模型上均显示出更好的耐受性和可接受性。从研究中获得的结果加强了Bhut Jolokia半纯化提取物在作为局部镇痛药和抗关节炎药的纳米级囊泡载体中的潜在应用。结论:显着的积极结果,且半定量的载有Bhut Jolokia的核糖体纳米囊泡载体的辣椒素类提取物的刺激性降低,表明它可能是抗关节炎药物制剂开发的选择之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号